Skip to main content
Top
Published in: BMC Cancer 1/2007

Open Access 01-12-2007 | Research article

Aberrant over-expression of a forkhead family member, FOXO1A, in a brain tumor cell line

Authors: Peter B Dallas, Simone Egli, Philippa A Terry, Ursula R Kees

Published in: BMC Cancer | Issue 1/2007

Login to get access

Abstract

Background

The mammalian FOXO (forkhead box, O subclass) proteins are a family of pleiotropic transcription factors involved in the regulation of a broad range of cellular processes critical for survival. Despite the essential and diverse roles of the FOXO family members in human cells and their involvement in tumor pathogenesis, the regulation of FOXO expression remains poorly understood. We have addressed the mechanisms underlying the high level of expression of the FOXO1A gene in a cell line, PER-453, derived from a primitive neuroectodermal tumor of the central nervous system (CNS-PNET).

Methods

The status of the FOXO1A locus in the PER-453 CNS-PNET cell line was investigated by Southern blotting and DNA sequence analysis of the proximal promoter, 5'-UTR, open reading frame and 3'-UTR. FOXO1A expression was assessed by conventional and quantitative RT-PCR, Northern and Western blotting.

Results

Quantitative real-time RT-PCR (qRT-PCR) data indicated that after normalization to ACTB mRNA levels, canonical FOXO1A mRNA expression in the PER-453 cell line was 124-fold higher than the average level of five other CNS-PNET cell lines tested, 24-fold higher than the level in whole fetal brain, and 3.5-fold higher than the level in fetal brain germinal matrix cells. No mutations within the FOXO1A open reading frame or gross rearrangements of the FOXO1A locus were detected. However, a single nucleotide change within the proximal promoter and several nucleotide changes within the 3'-UTR were identified. In addition, two novel FOXO1A transcripts were isolated that differ from the canonical transcript by alternative splicing within the 3'-UTR.

Conclusion

The CNS-PNET cell line, PER-453, expresses FOXO1A at very high levels relative to most normal and cancer cells from a broad range of tissues. The FOXO1A open reading frame is wild type in the PER-453 cell line and the abnormally high FOXO1A mRNA expression is not due to mutations affecting the 5'-UTR or proximal promoter. Over expression of FOXO1A may be the result of PER-453 specific epimutations or imbalances in regulatory factors acting at the promoter and/or 3'-UTR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Birkenkamp KU, Coffer PJ: Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 2003, 31 (Pt 1): 292-297.CrossRefPubMed Birkenkamp KU, Coffer PJ: Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 2003, 31 (Pt 1): 292-297.CrossRefPubMed
2.
go back to reference Burgering BM, Kops GJ: Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 2002, 27 (7): 352-360. 10.1016/S0968-0004(02)02113-8.CrossRefPubMed Burgering BM, Kops GJ: Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 2002, 27 (7): 352-360. 10.1016/S0968-0004(02)02113-8.CrossRefPubMed
3.
go back to reference Hosaka T, Biggs WH, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC: Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004, 101 (9): 2975-2980. 10.1073/pnas.0400093101.CrossRefPubMedPubMedCentral Hosaka T, Biggs WH, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC: Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004, 101 (9): 2975-2980. 10.1073/pnas.0400093101.CrossRefPubMedPubMedCentral
4.
go back to reference Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004, 117 (4): 421-426. 10.1016/S0092-8674(04)00452-0.CrossRefPubMed Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004, 117 (4): 421-426. 10.1016/S0092-8674(04)00452-0.CrossRefPubMed
5.
go back to reference Burgering BM, Medema RH: Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003, 73 (6): 689-701. 10.1189/jlb.1202629.CrossRefPubMed Burgering BM, Medema RH: Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol. 2003, 73 (6): 689-701. 10.1189/jlb.1202629.CrossRefPubMed
6.
go back to reference Van Der Heide LP, Hoekman MF, Smidt MP: The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J. 2004, 380 (Pt 2): 297-309. 10.1042/BJ20040167.CrossRefPubMedPubMedCentral Van Der Heide LP, Hoekman MF, Smidt MP: The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J. 2004, 380 (Pt 2): 297-309. 10.1042/BJ20040167.CrossRefPubMedPubMedCentral
7.
go back to reference Arden KC: Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 2006, 41 (8): 709-717. 10.1016/j.exger.2006.05.015.CrossRefPubMed Arden KC: Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 2006, 41 (8): 709-717. 10.1016/j.exger.2006.05.015.CrossRefPubMed
8.
go back to reference Lam EW, Francis RE, Petkovic M: FOXO transcription factors: key regulators of cell fate. Biochem Soc Trans. 2006, 34 (Pt 5): 722-726.CrossRefPubMed Lam EW, Francis RE, Petkovic M: FOXO transcription factors: key regulators of cell fate. Biochem Soc Trans. 2006, 34 (Pt 5): 722-726.CrossRefPubMed
9.
go back to reference Seoane J, Le HV, Shen L, Anderson SA, Massague J: Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004, 117 (2): 211-223. 10.1016/S0092-8674(04)00298-3.CrossRefPubMed Seoane J, Le HV, Shen L, Anderson SA, Massague J: Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004, 117 (2): 211-223. 10.1016/S0092-8674(04)00298-3.CrossRefPubMed
10.
go back to reference Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell. 2002, 2 (1): 81-91. 10.1016/S1535-6108(02)00086-7.CrossRefPubMed Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell. 2002, 2 (1): 81-91. 10.1016/S1535-6108(02)00086-7.CrossRefPubMed
11.
go back to reference Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR: Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000, 20 (23): 8969-8982. 10.1128/MCB.20.23.8969-8982.2000.CrossRefPubMedPubMedCentral Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR: Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000, 20 (23): 8969-8982. 10.1128/MCB.20.23.8969-8982.2000.CrossRefPubMedPubMedCentral
12.
go back to reference Modur V, Nagarajan R, Evers BM, Milbrandt J: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002, 277 (49): 47928-47937. 10.1074/jbc.M207509200.CrossRefPubMed Modur V, Nagarajan R, Evers BM, Milbrandt J: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002, 277 (49): 47928-47937. 10.1074/jbc.M207509200.CrossRefPubMed
13.
go back to reference Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT: FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 2006, 66 (14): 6998-7006. 10.1158/0008-5472.CAN-06-0411.CrossRefPubMed Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT: FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 2006, 66 (14): 6998-7006. 10.1158/0008-5472.CAN-06-0411.CrossRefPubMed
14.
go back to reference Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC: Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 2003, 63 (1): 6-11.PubMed Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC: Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 2003, 63 (1): 6-11.PubMed
15.
go back to reference Bois PR, Izeradjene K, Houghton PJ, Cleveland JL, Houghton JA, Grosveld GC: FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. J Cell Biol. 2005, 170 (6): 903-912. 10.1083/jcb.200501040.CrossRefPubMedPubMedCentral Bois PR, Izeradjene K, Houghton PJ, Cleveland JL, Houghton JA, Grosveld GC: FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma. J Cell Biol. 2005, 170 (6): 903-912. 10.1083/jcb.200501040.CrossRefPubMedPubMedCentral
16.
go back to reference Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W: AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol Cell Biol. 2003, 23 (1): 104-118. 10.1128/MCB.23.1.104-118.2003.CrossRefPubMedPubMedCentral Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W: AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Mol Cell Biol. 2003, 23 (1): 104-118. 10.1128/MCB.23.1.104-118.2003.CrossRefPubMedPubMedCentral
17.
go back to reference Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002, 415 (6870): 436-442. 10.1038/415436a.CrossRefPubMed Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002, 415 (6870): 436-442. 10.1038/415436a.CrossRefPubMed
18.
go back to reference Diccianni MB, Omura-Minamisawa M, Batova A, Le T, Bridgeman L, Yu AL: Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma. Int J Cancer. 1999, 80 (1): 145-154. 10.1002/(SICI)1097-0215(19990105)80:1<145::AID-IJC26>3.0.CO;2-G.CrossRefPubMed Diccianni MB, Omura-Minamisawa M, Batova A, Le T, Bridgeman L, Yu AL: Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma. Int J Cancer. 1999, 80 (1): 145-154. 10.1002/(SICI)1097-0215(19990105)80:1<145::AID-IJC26>3.0.CO;2-G.CrossRefPubMed
19.
go back to reference Burns AS, Jaros E, Cole M, Perry R, Pearson AJ, Lunec J: The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system. Br J Cancer. 2002, 86 (7): 1117-1123. 10.1038/sj.bjc.6600151.CrossRefPubMedPubMedCentral Burns AS, Jaros E, Cole M, Perry R, Pearson AJ, Lunec J: The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system. Br J Cancer. 2002, 86 (7): 1117-1123. 10.1038/sj.bjc.6600151.CrossRefPubMedPubMedCentral
20.
go back to reference Kees UR, Biegel JA, Ford J, Ranford PR, Peroni SE, Hallam LA, Parmiter AH, Willoughby ML, Spagnolo D: Enhanced MYCN expression and isochromosome 17q in pineoblastoma cell lines. Genes Chromosomes Cancer. 1994, 9 (2): 129-135. 10.1002/gcc.2870090209.CrossRefPubMed Kees UR, Biegel JA, Ford J, Ranford PR, Peroni SE, Hallam LA, Parmiter AH, Willoughby ML, Spagnolo D: Enhanced MYCN expression and isochromosome 17q in pineoblastoma cell lines. Genes Chromosomes Cancer. 1994, 9 (2): 129-135. 10.1002/gcc.2870090209.CrossRefPubMed
21.
go back to reference Kees UR, Spagnolo D, Hallam LA, Ford J, Ranford PR, Baker DL, Callen DF, Biegel JA: A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification. Cancer Genet Cytogenet. 1998, 100 (2): 159-164. 10.1016/S0165-4608(97)00030-7.CrossRefPubMed Kees UR, Spagnolo D, Hallam LA, Ford J, Ranford PR, Baker DL, Callen DF, Biegel JA: A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification. Cancer Genet Cytogenet. 1998, 100 (2): 159-164. 10.1016/S0165-4608(97)00030-7.CrossRefPubMed
22.
go back to reference Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol. 1985, 44 (5): 472-485.CrossRefPubMed Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol. 1985, 44 (5): 472-485.CrossRefPubMed
23.
go back to reference Hoffmann K, Firth MJ, Freitas JR, de Klerk NH, Kees UR: Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Molecular Biotechnology. 2005, 29: 31-38. 10.1385/MB:29:1:31.CrossRefPubMed Hoffmann K, Firth MJ, Freitas JR, de Klerk NH, Kees UR: Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Molecular Biotechnology. 2005, 29: 31-38. 10.1385/MB:29:1:31.CrossRefPubMed
24.
go back to reference Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC: Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics. 1998, 47 (2): 187-199. 10.1006/geno.1997.5122.CrossRefPubMed Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC: Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics. 1998, 47 (2): 187-199. 10.1006/geno.1997.5122.CrossRefPubMed
25.
go back to reference Davis RJ, Bennicelli JL, Macina RA, Nycum LM, Biegel JA, Barr FG: Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum Mol Genet. 1995, 4 (12): 2355-2362. 10.1093/hmg/4.12.2355.CrossRefPubMed Davis RJ, Bennicelli JL, Macina RA, Nycum LM, Biegel JA, Barr FG: Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum Mol Genet. 1995, 4 (12): 2355-2362. 10.1093/hmg/4.12.2355.CrossRefPubMed
26.
go back to reference Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995, 23 (23): 4878-4884. 10.1093/nar/23.23.4878.CrossRefPubMedPubMedCentral Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995, 23 (23): 4878-4884. 10.1093/nar/23.23.4878.CrossRefPubMedPubMedCentral
27.
go back to reference Suske G: The Sp-family of transcription factors. Gene. 1999, 238 (2): 291-300. 10.1016/S0378-1119(99)00357-1.CrossRefPubMed Suske G: The Sp-family of transcription factors. Gene. 1999, 238 (2): 291-300. 10.1016/S0378-1119(99)00357-1.CrossRefPubMed
28.
go back to reference Furuyama T, Nakazawa T, Nakano I, Mori N: Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J. 2000, 349 (Pt 2): 629-634. 10.1042/0264-6021:3490629.CrossRefPubMedPubMedCentral Furuyama T, Nakazawa T, Nakano I, Mori N: Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J. 2000, 349 (Pt 2): 629-634. 10.1042/0264-6021:3490629.CrossRefPubMedPubMedCentral
29.
go back to reference Massague J: G1 cell-cycle control and cancer. Nature. 2004, 432 (7015): 298-306. 10.1038/nature03094.CrossRefPubMed Massague J: G1 cell-cycle control and cancer. Nature. 2004, 432 (7015): 298-306. 10.1038/nature03094.CrossRefPubMed
30.
go back to reference Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004, 101 (16): 6062-6067. 10.1073/pnas.0400782101.CrossRefPubMedPubMedCentral Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004, 101 (16): 6062-6067. 10.1073/pnas.0400782101.CrossRefPubMedPubMedCentral
31.
go back to reference Carlsson P, Mahlapuu M: Forkhead transcription factors: key players in development and metabolism. Dev Biol. 2002, 250 (1): 1-23. 10.1006/dbio.2002.0780.CrossRefPubMed Carlsson P, Mahlapuu M: Forkhead transcription factors: key players in development and metabolism. Dev Biol. 2002, 250 (1): 1-23. 10.1006/dbio.2002.0780.CrossRefPubMed
32.
go back to reference Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, Emanuel BS, Rovera G, Barr FG: Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993, 5 (3): 230-235. 10.1038/ng1193-230.CrossRefPubMed Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, Emanuel BS, Rovera G, Barr FG: Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993, 5 (3): 230-235. 10.1038/ng1193-230.CrossRefPubMed
33.
go back to reference So CW, Cleary ML: Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 2003, 101 (2): 633-639. 10.1182/blood-2002-06-1785.CrossRefPubMed So CW, Cleary ML: Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 2003, 101 (2): 633-639. 10.1182/blood-2002-06-1785.CrossRefPubMed
34.
go back to reference Hapgood JP, Riedemann J, Scherer SD: Regulation of gene expression by GC-rich DNA cis-elements. Cell Biol Int. 2001, 25 (1): 17-31. 10.1006/cbir.2000.0674.CrossRefPubMed Hapgood JP, Riedemann J, Scherer SD: Regulation of gene expression by GC-rich DNA cis-elements. Cell Biol Int. 2001, 25 (1): 17-31. 10.1006/cbir.2000.0674.CrossRefPubMed
35.
go back to reference Kuersten S, Goodwin EB: The power of the 3' UTR: translational control and development. Nat Rev Genet. 2003, 4 (8): 626-637. 10.1038/nrg1125.CrossRefPubMed Kuersten S, Goodwin EB: The power of the 3' UTR: translational control and development. Nat Rev Genet. 2003, 4 (8): 626-637. 10.1038/nrg1125.CrossRefPubMed
36.
go back to reference Rajasekhar VK, Holland EC: Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene. 2004, 23 (18): 3248-3264. 10.1038/sj.onc.1207546.CrossRefPubMed Rajasekhar VK, Holland EC: Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene. 2004, 23 (18): 3248-3264. 10.1038/sj.onc.1207546.CrossRefPubMed
37.
go back to reference Pesole G, Liuni S, Grillo G, Licciulli F, Mignone F, Gissi C, Saccone C: UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res. 2002, 30 (1): 335-340. 10.1093/nar/30.1.335.CrossRefPubMedPubMedCentral Pesole G, Liuni S, Grillo G, Licciulli F, Mignone F, Gissi C, Saccone C: UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res. 2002, 30 (1): 335-340. 10.1093/nar/30.1.335.CrossRefPubMedPubMedCentral
38.
go back to reference Lai EC, Tam B, Rubin GM: Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Genes Dev. 2005, 19 (9): 1067-1080. 10.1101/gad.1291905.CrossRefPubMedPubMedCentral Lai EC, Tam B, Rubin GM: Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Genes Dev. 2005, 19 (9): 1067-1080. 10.1101/gad.1291905.CrossRefPubMedPubMedCentral
39.
go back to reference Arden KC: FoxO: linking new signaling pathways. Mol Cell. 2004, 14 (4): 416-418. 10.1016/S1097-2765(04)00213-8.CrossRefPubMed Arden KC: FoxO: linking new signaling pathways. Mol Cell. 2004, 14 (4): 416-418. 10.1016/S1097-2765(04)00213-8.CrossRefPubMed
40.
go back to reference You H, Mak TW: Crosstalk between p53 and FOXO transcription factors. Cell Cycle. 2005, 4 (1): 37-38.CrossRefPubMed You H, Mak TW: Crosstalk between p53 and FOXO transcription factors. Cell Cycle. 2005, 4 (1): 37-38.CrossRefPubMed
Metadata
Title
Aberrant over-expression of a forkhead family member, FOXO1A, in a brain tumor cell line
Authors
Peter B Dallas
Simone Egli
Philippa A Terry
Ursula R Kees
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2007
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-7-67

Other articles of this Issue 1/2007

BMC Cancer 1/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine